Clinical Trials Management System Market Share

Global Clinical Trials Management System (CTMS) Market Report By Component (Software, Hardware, And Services), Delivery Mode (Web-Based, Cloud-Based, And On Premise), Product (Enterprise Based, And Site Based), End-User (Pharmaceuticals & Biopharmaceuticals Companies, Clinical Research Organizations, And Healthcare Providers) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210452

February 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study, the Global Clinical Trials Management System (CTMS) Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of XX.X%.

Clinical trials management system (CTMS) is a software system designed for life science industry. This software is used for managing clinical trials including planning, preparation, and performance and reporting in clinical research. It is designed to keep the up-to-date contact information of the participants and track deadlines for reports and regulatory approval. In addition, it also provides a user-friendly interface, which avoids complexities for the clinician while managing records.

Market Dynamics

The growing usage of information technology (IT) in healthcare and life science industries is driving the demand of clinical trials management system (CTMS) in the market. Increasing expenditure on R&D by clinical research organizations, such as IFPMA is another factor fuelling the market growth. In addition to this, rising government funding and investments for biotechnology and pharmaceutical are also propelling the market growth. However, high cost associated with CTMS may hamper the market growth. Nevertheless, a cloud-based delivery of the clinical trials management system (CTMS) is expected to spur the opportunity in the forecast timeframe.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of clinical trials management system (CTMS).

Market Segmentation
The broad clinical trials management system (CTMS) market has been sub-grouped into component, delivery mode, product and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Component

Software
Hardware
Services

By Delivery Mode

Web-Based
Cloud-Based
On Premise

By Product

Enterprise Based
Site Based

By End-User

Pharmaceuticals & Biopharmaceuticals Companies
Clinical Research Organizations
Healthcare Providers

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for clinical trials management system (CTMS) in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Clinical Trials Management System (CTMS) Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the clinical trials management system (CTMS) market includes DATATRAK International, Forte Research Systems, Medidata Solutions, MedNet Solutions, Merge Healthcare (IBM Watson), Omnicomm Systems, Oracle Corporation and Parexel International Corp. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Clinical Trials Management System Market
       2.2. Global Clinical Trials Management System Market Snapshot

3 . CLINICAL TRIALS MANAGEMENT SYSTEM – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Clinical Trials Management System Market
       3.3. Market Restraints of Clinical Trials Management System Market
       3.4. Opportunities of Clinical Trials Management System Market
       3.5. Trends of Clinical Trials Management System Market
       3.6. Porter’s Five Force Analysis of Clinical Trials Management System Market
       3.7. Clinical Trials Management System Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Component
           3.7.2 Market Attractive Analysis by Delivery Mode
           3.7.3 Market Attractive Analysis by Product
           3.7.4 Market Attractive Analysis by End-User
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Clinical Trials Management System Value Chain Analysis
       4.2. Clinical Trials Management System Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Clinical Trials Management System Raw Material Manufactures List
           4.2.3. Price Trend of Clinical Trials Management System Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY COMPONENT
       5.1 Overview by Component
       5.2 Global Clinical Trials Management System Market Analysis by Component
       5.3 Market Analysis of Software by Regions
       5.4 Market Analysis of Hardware by Regions
       5.5 Market Analysis of Services by Regions

6 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY DELIVERY MODE
       6.1 Overview by Delivery Mode
       6.2 Global Clinical Trials Management System Market Analysis by Delivery Mode
       6.3 Market Analysis of Web-Based by Regions
       6.4 Market Analysis of Cloud-Based by Regions
       6.5 Market Analysis of On Premise by Regions

7 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY PRODUCT
       7.1 Overview by Product
       7.2 Global Clinical Trials Management System Market Analysis by Product
       7.3 Market Analysis of Enterprise Based by Regions
       7.4 Market Analysis of Site Based by Regions

8 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY END-USER
       8.1 Overview by End-User
      8.2 Global Clinical Trials Management System Market Analysis by End-User
       8.3 Market Analysis of Pharmaceuticals & Biopharmaceuticals Companies by Regions
       8.4 Market Analysis of Clinical Research Organizations by Regions
       8.5 Market Analysis of Healthcare Providers by Regions

9 . GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Clinical Trials Management System Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Clinical Trials Management System Market Estimate by Market Segment
           9.4.3. Europe Clinical Trials Management System Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Clinical Trials Management System Market Estimate by Market Segment
           9.5.3. Asia Pacific Clinical Trials Management System Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Clinical Trials Management System Market Estimate by Market Segment
           9.6.3. Latin America Clinical Trials Management System Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Clinical Trials Management System Market Estimate by Market Segment
           9.7.3. Middle East & Africa Clinical Trials Management System Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa

10 COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS MANAGEMENT SYSTEM COMPANIES
       10.1. Clinical Trials Management System Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 COMPANY PROFILES OF CLINICAL TRIALS MANAGEMENT SYSTEM INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. DATATRAK International
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Forte Research Systems
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Medidata Solutions
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. MedNet Solutions
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Merge Healthcare (IBM Watson)
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Omnicomm Systems
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Oracle Corporation
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Parexel International Corp.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments

12. IMPACT ANALYSIS OF COVID-19 OUTBREAK
12.1. Impact Analysis of Covid-19 Outbreak on the Market
12.1.1. Direct Impact on Production
12.1.2. Supply Chain and Market Disruption
12.1.3. Financial Impact on Firms and Financial Markets
12.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
12.3. Pre V/S Post COVID-19 Market
12.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
12.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210452

February 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11210452

February 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact